These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23840456)

  • 1. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans.
    Fagundo AB; de la Torre R; Jiménez-Murcia S; Agüera Z; Pastor A; Casanueva FF; Granero R; Baños R; Botella C; Del Pino-Gutierrez A; Fernández-Real JM; Fernández-García JC; Frühbeck G; Gómez-Ambrosi J; Menchón JM; Moragrega I; Rodríguez R; Tárrega S; Tinahones FJ; Fernández-Aranda F
    PLoS One; 2013; 8(6):e66387. PubMed ID: 23840456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
    Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
    Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
    PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids concentrations in plasma associated with feed efficiency and carcass composition of beef steers.
    Artegoitia VM; Foote AP; Lewis RM; King DA; Shackelford SD; Wheeler TL; Freetly HC
    J Anim Sci; 2016 Dec; 94(12):5177-5181. PubMed ID: 28046144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
    Thompson Z; Argueta D; Garland T; DiPatrizio N
    Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of dietary patterns with endocannabinoids levels in overweight and obese women.
    Yagin NL; Hajjarzadeh S; Aliasgharzadeh S; Aliasgari F; Mahdavi R
    Lipids Health Dis; 2020 Jul; 19(1):161. PubMed ID: 32631352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline.
    Altamura C; Ventriglia M; Martini MG; Montesano D; Errante Y; Piscitelli F; Scrascia F; Quattrocchi C; Palazzo P; Seccia S; Vernieri F; Di Marzo V
    J Alzheimers Dis; 2015; 46(2):497-506. PubMed ID: 25818503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endocannabinoids and affect regulation in human subjects.
    Coccaro EF; Hill MN; Robinson L; Lee RJ
    Psychoneuroendocrinology; 2018 Jun; 92():66-71. PubMed ID: 29627714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
    Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D
    Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Plasma Endocannabinoids and the Hypothalamic Endocannabinoid System in Increasing Feed Intake after Parturition of Dairy Cows.
    Kuhla B; Kaever V; Tuchscherer A; Kuhla A
    Neuroendocrinology; 2020; 110(3-4):246-257. PubMed ID: 31141804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism.
    Navarini L; Bisogno T; Mozetic P; Piscitelli F; Margiotta DPE; Basta F; Afeltra A; Maccarrone M
    Int J Biochem Cell Biol; 2018 Jun; 99():161-168. PubMed ID: 29655919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
    Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
    Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans.
    Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G
    Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
    Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
    Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.
    Heyman E; Gamelin FX; Goekint M; Piscitelli F; Roelands B; Leclair E; Di Marzo V; Meeusen R
    Psychoneuroendocrinology; 2012 Jun; 37(6):844-51. PubMed ID: 22029953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea.
    Wang X; Yu Q; Yue H; Zhang J; Zeng S; Cui F
    Biomed Res Int; 2016; 2016():9782031. PubMed ID: 26904688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study.
    Wingenfeld K; Dettenborn L; Kirschbaum C; Gao W; Otte C; Roepke S
    Stress; 2018 Jul; 21(4):366-369. PubMed ID: 29546791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.